Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec;8(4):1519-1534.
doi: 10.1007/s40744-021-00378-w. Epub 2021 Oct 1.

Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-Analysis

Alen Zabotti  1   2 , Orazio De Lucia  3 , Garifallia Sakellariou  4 , Alberto Batticciotto  5 , Gilberto Cincinelli  3 , Ivan Giovannini  6 , Luca Idolazzi  7 , Gabriella Maioli  3 , Ilaria Tinazzi  8 , Daniel Aletaha  9 , Salvatore De Vita  6 , Antonio Marchesoni  3 , Josef Smolen  9 , Annamaria Iagnocco  10 , Dennis McGonagle  11 , Roberto Caporali  3
Affiliations
Review

Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-Analysis

Alen Zabotti et al. Rheumatol Ther. 2021 Dec.

Abstract

Background: Agreement on how to identify psoriasis (PsO) patients at risk of developing psoriatic arthritis (PsA) is lacking.

Objective: To identify predictors, risk factors and incidence rate (IR) of PsA development in PsO patients through a systematic literature review (SLR) and meta-analyses (MA).

Methods: MEDLINE, Embase, and Cochrane databases were searched. Cohort studies were used to assess the predictors, while case-control studies for PsA risk factor determination.

Results: We screened 4698 articles for eligibility, and 110 underwent a full reading and 26 were finally included. Among skin and nail phenotypes, PsO severity and nail pitting were selected as predictors of PsA development. Furthermore, PsO patients with arthralgia (pooled RR 2.15 [1.16; 3.99]) and/or with imaging-MSK inflammation (pooled RR 3.72 [2.12; 6.51]) were at high risk of PsA. Higher categories of BMI and a family history of PsA were other predictors. In outpatient-based cohort studies, the IR of PsA per 100 patient-years varied from 1.34 to 17.4.

Limitations: Despite the strength of the overall results, the heterogeneity and the number of the cohort studies could be considered a limitation.

Conclusions: This study provides a tentative profile of the PsO patient at risk of PsA and will help the design of PsA prevention trials.

Keywords: Disease interception; Disease prevention; Early psoriatic arthritis; Psoriasis; Psoriatic arthritis; Systematic review.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
PRISMA flow diagram
Fig. 2
Fig. 2
Forest plot of the pooled estimates of the main potential predictors of PsA, nail involvement (A), musculoskeletal complaints (B), and inflammation and structural damage detected by imaging (C)
Fig. 3
Fig. 3
Synthesis of the potential predictors of PsA development in PsO patients
See this image and copyright information in PMC

References

    1. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(Suppl 2):ii14–17. - PMC - PubMed
    1. Christophers E, Barker JNWN, Griffiths CEM, Daudén E, Milligan G, Molta C, et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol. 2010;24:548–554. doi: 10.1111/j.1468-3083.2009.03463.x. - DOI - PubMed
    1. Gossec L, Baraliakos X, Kerschbaumer A, de Wit M, McInnes I, Dougados M, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. Ann Rheum Dis. 2020;79:700–712. - PMC - PubMed
    1. Scher JU, Ogdie A, Merola JF, Ritchlin C. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition. Nat Rev Rheumatol Nat Publ Group. 2019;15:153–166. doi: 10.1038/s41584-019-0175-0. - DOI - PubMed
    1. Zabotti A, McGonagle DG, Giovannini I, Errichetti E, Zuliani F, Zanetti A, et al. Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia. RMD Open. 2019;5:e001067. doi: 10.1136/rmdopen-2019-001067. - DOI - PMC - PubMed